STOCK TITAN

DEFSEC Technologies Inc. Announces Strong Second Quarter

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

DEFSEC Technologies (NASDAQ: DFSC) reported Q2 Fiscal 2026 revenue of $2.12 million, up 68% year-over-year, with government subcontract task order revenue up 81%. Gross margin rose to $626k, and gross margin percentage increased 19% over Fiscal 2025.

Defense program billings reached an annualized run-rate of about $9.41 million. Cash and short-term investments were $3.0 million, with trade receivables of $2.0 million. The company highlighted first PARA SHOT sales, BLISS prototype deliveries, DEFSEC Lightning SaaS release, and commercial launch of ARWEN 40mm ammunition, plus a new U.S. law-enforcement customer.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Q2 2026 revenue $2.12M, up 68% year-over-year
  • Government subcontract revenue up 81% versus Q2 2025
  • Gross margin increased to $626k from $314k year-over-year
  • Defense program annualized billings run-rate approximately $9.41M
  • Cash and receivables total about $5.0M at March 31, 2026
  • Commercial launches of PARA SHOT, BLISS prototype, Lightning SaaS, and ARWEN 40mm

Negative

  • Adjusted EBITDA loss widened to $1.74M from $1.42M year-over-year
  • Operating expenses rose to $2.53M from $2.05M year-over-year
  • Cash and short-term investments fell to $3.0M from $6.73M
  • Working capital declined to $3.59M from $6.03M
  • Grant of 151,552 stock options adds potential equity dilution

News Market Reaction – DFSC

-13.33%
14 alerts
-13.33% News Effect
-20.7% Trough in 33 hr 17 min
-$2M Valuation Impact
$9.87M Market Cap
0.9x Rel. Volume

On the day this news was published, DFSC declined 13.33%, reflecting a significant negative market reaction. Argus tracked a trough of -20.7% from its starting point during tracking. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $9.87M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Q2 2026 revenue: $2,119.7K Q2 2025 revenue: $1,264.2K Revenue growth: 68% +5 more
8 metrics
Q2 2026 revenue $2,119.7K Three months ended March 31, 2026
Q2 2025 revenue $1,264.2K Three months ended March 31, 2025
Revenue growth 68% Total revenue growth vs Q2 Fiscal 2025
Gov’t program revenue growth 81% Revenue on Government programs vs Q2 Fiscal 2025
Q2 2026 adjusted EBITDA ($1,738.3K) Adjusted EBITDA loss, three months ended March 31, 2026
Cash & short-term investments $2,998.5K As at March 31, 2026
Defense billings run-rate $9.41M Annualized go-forward program billings after adding resources
Potential subcontract revenue $75M Combined revenue through initial DSEF and Land C4ISR contract periods

Market Reality Check

Price: $4.06 Vol: Price was down 2.22% on v...
low vol
$4.06 Last Close
Volume Price was down 2.22% on volume of 128,590, below the 233,830 20-day average (relative volume 0.55) ahead of this earnings update. low
Technical Shares at $4.84 were trading above the $2.95 200-day MA, but still 64.8% below the 52-week high and 198.77% above the 52-week low.

Peers on Argus

DFSC slipped 2.22% while peers were mixed: GPUS in momentum scanners was down, P...
1 Down

DFSC slipped 2.22% while peers were mixed: GPUS in momentum scanners was down, PRZO and MNTS were up, and AIRI and KITT were down. Movements do not show a unified Aerospace & Defense trend.

Common Catalyst Same-day peer headlines focused on product demonstrations (PRZO counter-drone solution) and leadership changes (KITT CRO appointment), suggesting stock-specific rather than sector-wide drivers.

Historical Context

5 past events · Latest: May 06 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
May 06 Product launch Positive +11.3% Commercial release of Lightning™ real-time situational awareness SaaS platform.
Apr 29 Product shipment Positive +20.9% Shipment of BLISS units to U.S. Army Yuma Test Center for evaluation.
Apr 20 Board changes Positive +24.0% New director with major defense experience joins board, another retires.
Mar 31 Product announcement Positive +5.2% Announcement of BLISS next‑generation laser identification system and software suite.
Feb 23 AGM results Positive +2.7% Shareholders approve board size, director slate, auditor and long‑term incentive plan.
Pattern Detected

Recent DEFSEC news on product launches and leadership changes has generally coincided with positive price reactions, indicating the stock often responds favorably to growth and strategic updates.

Recent Company History

Over the last few months, DEFSEC has reported multiple positive developments including BLISS sensor announcements (Mar 31), shipments to the U.S. Army (Apr 29), the Lightning™ SaaS commercial release (May 6), and governance changes strengthening the board (Apr 20). Each of these news items saw single- to double-digit percentage gains within 24 hours. Today’s Q2 Fiscal 2026 results and product milestones extend this trajectory of defense digitization growth and commercialization across BLISS, PARA SHOTTM and Lightning™.

Regulatory & Risk Context

Active S-3 Shelf · CAD$2.61 million
Shelf Active
Active S-3 Shelf Registration 2026-02-02
CAD$2.61 million registered capacity

An effective Form F-3 dated Feb 2, 2026 registers up to 608,493 common shares for resale upon exercise of existing investor and placement agent warrants at exercise prices of CAD$4.27 and CAD$4.55. DEFSEC will not sell primary shares under this shelf but may receive up to CAD$2.61 million if all warrants are exercised for cash, increasing shares outstanding from 1,993,626 to 2,602,119. No usage of this shelf has been recorded so far.

Market Pulse Summary

The stock dropped -13.3% in the session following this news. A negative reaction despite strong reve...
Analysis

The stock dropped -13.3% in the session following this news. A negative reaction despite strong revenue growth could fit concerns highlighted in the financials, such as the Q2 adjusted EBITDA loss of ($1.74M) and declining working capital versus September 2025. While defense software billings reached a $9.41M annualized run‑rate and total revenue grew 68%, the company remains loss‑making. The effective Form F‑3 registering 608,493 warrant shares and potential share count increase to 2,602,119 may also factor into risk assessments.

Key Terms

adjusted ebitda, non-ifrs measures, stock options, less-lethal, +1 more
5 terms
adjusted ebitda financial
"Adjusted EBITDA loss 2 | (1,738.3) | (1,422.3)"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
non-ifrs measures financial
"Unaudited, non-IFRS measure. See " Non-IFRS Measures " in this news release."
Non-IFRS measures are financial figures that companies create on their own to show aspects of their performance, beyond what standard accounting rules require. They can help investors better understand how a company is really doing by highlighting information that might be more relevant or easier to interpret, much like a sports coach emphasizes certain stats to showcase team strengths not captured by official scores.
stock options financial
"The Company has granted an aggregate of 151,552 stock options to directors and officers"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
less-lethal technical
"continued growth in its ARWEN® less-lethal product line with the adoption of the ARWEN® 37"
Less-lethal describes weapons, devices or tools designed to stop, restrain or disperse people while aiming to reduce the chance of causing death, examples include tasers, pepper spray, and rubber-bullet systems. It matters to investors because products labeled less-lethal sit at the intersection of law, regulation, public opinion and liability — like choosing a rubber mallet instead of a steel hammer, companies may gain access to large markets but also face tighter rules, reputational risk and potential lawsuits that affect sales and valuation.
saas technical
"commercial release of its DEFSEC LightningTM SaaS product for Critical Incident Management Systems."
SaaS, or Software as a Service, is a way of delivering computer programs over the internet, allowing users to access and use them through a web browser without needing to install or maintain the software themselves. For investors, it highlights a business model where companies generate recurring revenue by providing ongoing access to their software, often leading to predictable income and growth potential.

AI-generated analysis. Not financial advice.

 Fiscal 2026 Results and Achievement of Significant Product Milestones

  • Revenue on Government programs up 81% from Q2 Fiscal 2025, with total revenue up 68% over the period;
  • Gross margin % up 19% over Fiscal 2025;
  • Defense program billings on an annualized go-forward basis reach approximately $9.41 million;
  • Commercial launch of ARWEN® 40mm baton ammunition;
  • First shipment of PARA SHOTTM system to Public Safety customer; and
  • Strong cash and AR position of +$5 million.

OTTAWA, ON, May 13, 2026 /PRNewswire/ - DEFSEC Technologies Inc. (TSXV: DFSC) and (TSXV: DFSC.WT.U); (NASDAQ: DFSC) and (NASDAQ: DFSCW) ("DEFSEC" or the "Company") is pleased to announce the highlights of its Fiscal 2026 second quarter ("Q2 Fiscal 2026") results. This announcement is a summary only and should be read in conjunction with DEFSEC's unaudited condensed consolidated interim financial statements for the three and six months ended March 31, 2026 and 2025 and related management's discussion and analysis for the three and six months ended March 31, 2026, all of which have been filed on SEDAR+ and EDGAR.  All figures are stated in Canadian Dollars unless otherwise noted.

Growth in defence software business

In the second quarter of Fiscal 2026 revenue from subcontract task orders increased 81% as compared to the second quarter of Fiscal 2025.  This revenue relates to the Company's software services for the Canadian Department of National Defence under two foundational long-term program subcontracts: (i) Directorate Land Command Systems Program Management Software Engineering Facility ("DSEF"); and (ii) Land Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance ("Land C4ISR") program, for the digital modernisation of the Canadian Forces. While these programs are "as and when requested" task-based contracts with no minimum guaranteed values, the Company's workshare for these multi-year contracts, excluding renewal options, would provide for up to $75 million in combined revenue through the initial contract periods that run through 2028 for DSEF and 2029 for Land C4ISR. Q2 Fiscal 2026 included the first two months of the previously announced work scope expansion on the DSEF program, which resulted in the addition of 14 new roles at the beginning of February.

At the end of Q2 Fiscal 2026, the Company had 43 resources working across the Land C4ISR and DSEF programs, an increase from 19 at the end of Q2 Fiscal 2025. Subsequent to the end of the quarter, two additional resources were added to the programs resulting in program billings on an annualized go-forward basis of approximately $9.41 million.

"We are pleased with the continued growth in program billings and the milestones achieved in Q2 in bringing our new products to market," said Mr. Homuth, President and CEO of DEFSEC. "We expect continued momentum in revenue growth as we ramp up further on these very strategic programs, consistent with Canada's renewed focus on sovereign defence spending and investment."

____________________________

1 Unaudited, non-IFRS measure. See "Non-IFRS Measures" in this news release.

Product launch milestones achieved

As of the date of this press release, the Company has achieved significant milestones with its product roadmap, which includes the Company's first sale of its PARA SHOTTM ammunition, the delivery of its BLISSTM prototype to customers for qualification and trials and the commercial release of its DEFSEC LightningTM SaaS product for Critical Incident Management Systems.

"Achieving these product commercialization milestones is a significant step towards further revenue growth and diversification," said Mr. Homuth.

Q2 Fiscal 2026 Financial Highlights:


Three months ended March 31,

(in thousands of $)

2026

2025


$

$

Revenue

2,119.7

1,264.2

Gross margin

626.0

314.0

Operating expenses

2,534.7

2,048.6

Adjusted EBITDA loss2

(1,738.3)

(1,422.3)

 

As at

March 31, 2026

September 30, 2025

(in thousands of $)

$

$

Cash and short-term investments

2,998.5

6,733.9

Trade and other receivables

2,014.0

1,494,2

Current assets

6,116.7

8,946.0

Total assets

9,809.3

12,921.5

Current liabilities

2,523.4

2,918.2

Total liabilities

4,684.4

5,119.8

Working capital

3,593.3

6,027.8

Commercial Launch of ARWEN® 40mm ammunition

The Company is pleased to announce continued growth in its ARWEN® less-lethal product line with the adoption of the ARWEN® 37 platform by a new law enforcement customer in the Western United States for use by its tactical team. In addition, this U.S. law enforcement customer has ordered DEFSEC's recently released ARWEN® 40mm baton ammunition, now in full-rate production, for use with their existing installed base of third-party 40mm launchers. Due to its significant size, the 40mm segment of the less-lethal market represents a significant opportunity for meaningful expansion of the ARWEN® business. This latest customer adoption further validates DEFSEC's ARWEN® growth strategy and reflects the competitive advantage of the ARWEN® system, driven by its demonstrated performance, reliability, and mission-focused design.

Stock Option Grant

The Company has granted an aggregate of 151,552 stock options to directors and officers, certain senior managers and consultants pursuant to its Amended and Restated Long-Term Performance Incentive Plan approved by its shareholders on February 19, 2026. The options vest one half immediately and one half on the first anniversary of granting and are exercisable at a price per share equal to the market price as at the close of trading today on the TSXV ($6.75), for a period of three years from the date of grant. The options and their terms are subject to the approval of the TSX Venture Exchange.  The maximum number of Shares issuable under the option plan pursuant to the Amended and Restated Long-Term Performance Incentive Plan shall not exceed 10% of the Company's issued and outstanding shares at the date of any Stock Option Grant (199,362 at present), and in addition the maximum number of Shares issuable in respect of Deferred Share Units, Restricted Share Units, Performance Share Units and Stock Appreciation Rights shall not exceed 199,362 at any point in time.

______________________________

2 Unaudited, non-IFRS measure. See "Non-IFRS Measures" in this news release.

About DEFSEC

DEFSEC (TSXV: DFSC) (TSXV: DFSC.WT.U) (NASDAQ: DFSC) (NASDAQ: DFSCSW) (FSE: 62UA) develops and commercializes breakthrough next-generation tactical systems for military and security forces. The Company's current portfolio of offerings includes digitization of tactical forces for real-time shared situational awareness and targeting information from any source (including drones) streamed directly to users' smart devices and weapons. Other DEFSEC products include countermeasures against threats such as electronic detection, lasers and drones. These systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems, and all come integrated with TAK. The Company also has a new proprietary less-lethal product line branded PARA SHOTTM with applications across all segments of the less-lethal market, including law enforcement. The Company is headquartered in Ottawa, Canada.

For more information, please visit https://www.defsectec.com.

Forward-Looking Statements

This news release contains "forward-looking statements" and "forward-looking information" within the meaning of Canadian and United States securities laws (collectively, "forward-looking statements"), which may be identified by the use of terms and phrases such as "may", "would", "should", "could", "expect", "intend", "estimate", "anticipate", "plan", "foresee", "have sight of", "believe", or "continue", the description of "optimism", "momentum" or "interest",  the negative of these terms and similar terminology, including references to assumptions, although not all forward-looking statements contain these terms and phrases. Forward-looking statements are provided for the purpose of assisting the reader in understanding us, our business, operations, prospects and risks at a point in time in the context of historical and possible future developments and therefore the reader is cautioned that such information may not be appropriate for other purposes. Such forward-looking statements are based on the current expectations of DEFSEC's management and are based on assumptions and subject to risks and uncertainties that are documented in detail in the Company's public filings. Forward-looking statements included in this include, but are not limited to: management's belief of sufficiency of available financial resources to support forecasted activities in 2026 based on cash on hand, anticipated revenue streams and planned expenditures in the fiscal year, subject to execution of the Company's operating plan and other risks and factors described  in its public filings; interest in DEFSEC LightningTM or other products and services as well as timing of full implementation or commercial release thereof; the Company's estimates of increases to annualized gross margin on a go-forward basis and extent thereof, if any; the stage of scaled production for the PARA SHOTTM technology into new training cartridges and timing of release thereof; and management's belief that its extensive customer base of law enforcement agencies for ARWEN® throughout North America is a ready market for its new products like PARA SHOTTM as well as DEFSEC LightningTM.

Although DEFSEC's management believes that the assumptions underlying such forward-looking statements are reasonable, they may prove to be incorrect. The forward-looking statements discussed in this news release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting DEFSEC, including DEFSEC's inability to execute on its current operating plan and/or fiscal 2026 forecasted activities, DEFSEC's inability to secure contracts and subcontracts (on the timelines, size and scale expected or at all), statements of work and orders for its products in fiscal 2026 and onwards for reasons beyond its control, the renewal or extension of agreements beyond their original term, the granting of patents applied for by DEFSEC, inability to finance the scale up to full commercial production levels for its physical products, inability to secure key partnership agreements to facilitate the outsourcing and logistics for its ARWEN® and PARA SHOTTM products, inability to commercialize DEFSEC's Battlespace Laser Identification Sensor System (BLISSTM), inability to secure or complete the execution of government contracts, inability to drive growth in DEFSEC's ARWEN® product line, inability to advance the commercialization of DEFSEC's PARA SHOTTM products, delay or inability to launch DEFSEC's Lightning SaaS offering, lower than expected or delayed demand for DEFSEC's BLISSTM, overall interest in DEFSEC's products being lower than anticipated or expected; general economic and stock market conditions; a stagnation or decrease in North American defence and public safety spending, adverse industry events; future legislative and regulatory developments in Canada, the United States and elsewhere; the inability of DEFSEC to implement and execute its business strategies; risks and uncertainties detailed from time to time in DEFSEC's filings with the Canadian Security Administrators and the United States Securities and Exchange Commission, and many other factors beyond the control of DEFSEC. Although DEFSEC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and DEFSEC undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Neither the TSX Venture Exchange nor its respective Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Non-IFRS Measures

This news release makes reference to certain non-IFRS measures. These measures are not recognized measures under the International Financial Reporting Standards ("IFRS"), do not have a standardized meaning prescribed by IFRS, and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. 

The non-IFRS measures used in this news release include "program billings on an annualized go-forward basis" and "Adjusted EBITDA", which are unaudited, non-IFRS measures.

"Program billings on an annualized go-forward basis", refers to programmatic revenue based on the roles staffed for a full year at the program billing rate. Management believes program billings on annualized go-forward basis is a useful measure because it reflects management's estimate of annualized revenues based on current contractual taskings as of the date of this release. The most directly comparable financial measure that is disclosed in the financial statements of the Company to which the non-IFRS measure relates is revenue.

"Adjusted EBITDA" refers to the sum of revenue, cost of goods sold, general and administrative expense, sales and marketing expense, and research and development expense as determined by management. Adjusted EBITDA is provided to assist readers in determining the ability of the Company to generate cash from operations and to cover financial charges. Management believes that Adjusted EBITDA provides useful information to investors as it is an important indicator of an issuer's ability to generate liquidity through cash flow from operating activities and equity accounted investees. Adjusted EBITDA is also used by investors and analysts for assessing financial performance and for the purpose of valuing an issuer, including calculating financial and leverage ratios. The most directly comparable financial measure that is disclosed in the financial statements of the Company to which the non-IFRS measure relates is operating loss.

These non-IFRS financial measures reflect an additional way of viewing aspects of the Company's operations that, when viewed with IFRS results and the reconciliations to the corresponding IFRS financial measures, may provide a more complete understanding of factors and trends affecting the Company's business. Because non-IFRS financial measures exclude the effect of items that will increase or decrease the Company's reported results of operations, management strongly encourages investors to review the Company's consolidated financial statements and publicly filed reports in their entirety under the Company's profile on EDGAR and SEDAR+.  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/defsec-technologies-inc-announces-strong-second-quarter-302771563.html

SOURCE DEFSEC Technologies Inc

FAQ

What were DEFSEC (NASDAQ: DFSC) Q2 Fiscal 2026 revenues and margins?

DEFSEC reported Q2 Fiscal 2026 revenue of about $2.12 million and gross margin of $626,000. According to DEFSEC, this represents 68% year-over-year revenue growth and a gross margin percentage that improved by 19% compared with Fiscal 2025.

How much did DEFSEC government program revenue grow in Q2 2026?

Government subcontract task order revenue grew 81% in Q2 Fiscal 2026 versus Q2 Fiscal 2025. According to DEFSEC, this revenue is driven by Canadian defence software work under the DSEF and Land C4ISR programs that run through 2028 and 2029.

What is DEFSEC’s defense program billing run-rate after Q2 2026?

DEFSEC reported defense program billings on an annualized go-forward basis of approximately $9.41 million. According to DEFSEC, this reflects 43 resources on the programs at quarter-end, plus two added afterward, supporting multi-year Canadian defence modernization work.

What were DEFSEC’s cash, receivables, and working capital at March 31, 2026?

At March 31, 2026, DEFSEC had cash and short-term investments of $3.0 million and trade receivables of $2.0 million. According to DEFSEC, working capital totaled $3.59 million, down from $6.03 million at September 30, 2025.

Did DEFSEC report a profit or loss on an adjusted EBITDA basis in Q2 2026?

DEFSEC reported an adjusted EBITDA loss of about $1.74 million in Q2 Fiscal 2026. According to DEFSEC, this compares with a prior-year adjusted EBITDA loss of $1.42 million, reflecting higher operating expenses alongside rapid revenue growth.

What new products did DEFSEC highlight in its Q2 2026 results?

DEFSEC highlighted PARA SHOT ammunition sales, BLISS prototype deliveries, DEFSEC Lightning SaaS launch, and ARWEN 40mm baton ammunition commercialization. According to DEFSEC, these milestones support revenue diversification across less-lethal solutions and critical incident management software markets.

What stock options did DEFSEC grant alongside its Q2 2026 update?

DEFSEC granted 151,552 stock options to directors, officers, managers, and consultants at an exercise price of $6.75. According to DEFSEC, options vest half immediately and half after one year, with a three-year term, subject to TSX Venture Exchange approval.